New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Mettler-Toledo International Inc.
MTD
Shape
US Flag

NYSE

26B

Medical - Diagnostics & Research

Next Earning date - 13 Feb 2025

26B

Medical - Diagnostics & Research

Next Earning date - 13 Feb 2025

1251.20USD
Shape7.80 ( 0.63%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-43%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

19%

Quote Panel

Shape
Updated December 1, 2024
1W 2.18 % 1M -8.27 % 3M -10.50 % 1Y 13.45 %

Key Metrics

Shape
  • Market Cap

    26.40B


  • Shares Outstanding

    21.10M


  • Share in Float

    20.78M


  • Dividende

    0


  • Earning Date

    13 Feb 2025


  • Price Target

    1251.2


  • Average Volume

    131498


  • Beta

    1.159


  • Range

    1068.33-1546.93


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.mt.com


  • Sector

    Healthcare


Fundamentals

Shape

32.80x

P/E Ratio

7.02x

P/S Ratio

-172.56x

P/B Ratio

-13.5

Debt/Equity

21.1%

Net Margin

$37.0

EPS

How MTD compares to sector?

P/E Ratio

Relative Strength

Shape

MTD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4B

Shape313%

2025-Revenue

$42.29

Shape325%

2025-EPS

$1B

Shape278%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wells Fargo

initialise

Previous: Overweight

2024-08-27

Now: Equal-Weight

Jefferies

downgrade

Previous: Not converted

2024-06-03

Now: Underperform

J.P. Morgan

upgrade

Previous: Not converted

2022-12-20

Now: Neutral

Goldman Sachs

upgrade

Previous: Not converted

2022-11-08

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+15%

12.1
vs 10.53

Q1.23

arrow
arrow

+10%

8.69
vs 7.87

Q2.23

arrow
arrow

+9%

10.19
vs 9.39

Q3.23

arrow
arrow

-4%

9.8
vs 10.18

Q4.23

arrow
arrow

-22%

9.4
vs 12.1

Q1.24

arrow
arrow

+2%

8.89
vs 8.69

Q2.24

arrow
arrow

-5%

9.65
vs 10.19

Q3.24

arrow
arrow

+4%

10.21
vs 9.8

Q4.24

arrow
arrow

+25%

11.72
vs 9.4

Q1.25

arrow
arrow

-5%

8.43
vs 8.89

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+2%

1.1B  vs 1B

Q1.23

arrow
arrow

+3%

928.7M  vs 897.8M

Q2.23

arrow
arrow

+0%

982.1M  vs 978.4M

Q3.23

arrow
arrow

-4%

942.5M  vs 985.8M

Q4.23

arrow
arrow

-12%

935M  vs 1.1B

Q1.24

arrow
arrow

0%

925.9M  vs 928.7M

Q2.24

arrow
arrow

-4%

946.8M  vs 982.1M

Q3.24

arrow
arrow

+1%

954.5M  vs 942.5M

Q4.24

arrow
arrow

+8%

1B  vs 935M

Q1.25

arrow
arrow

-2%

911.4M  vs 925.9M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+1072%

10.72
vs -2.66

Q1.23

arrow
arrow

-770%

-7.70
vs 10.72

Q2.23

arrow
arrow

-238%

-2.38
vs -7.70

Q3.23

arrow
arrow

-190%

-1.90
vs -2.38

Q4.23

arrow
arrow

-123%

-1.23
vs -1.90

Q1.24

arrow
arrow

-112%

-1.12
vs -1.23

Q2.24

arrow
arrow

-145%

-1.45
vs -1.12

Q3.24

arrow
arrow

-137%

-1.37
vs -1.45

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

739

739
vs 713

4%

Q1.23

arrow
arrow

778

778
vs 739

5%

Q2.23

arrow
arrow

762

762
vs 778

-2%

Q3.23

arrow
arrow

738

738
vs 762

-3%

Q4.23

arrow
arrow

761

761
vs 738

3%

Q1.24

arrow
arrow

778

778
vs 761

2%

Q2.24

arrow
arrow

791

791
vs 778

2%

Q3.24

arrow
arrow

784

784
vs 791

-1%

Earnings Growth

Latest News